Menu Close

Carnicolin suspension 250ml

Rated 5.00 out of 5 based on 2 customer ratings
(2 customer reviews)

450,00 EGP

Carnicolin Suspension 250ml combines Citicoline, L-Carnitine, and Coenzyme Q10 to support brain health, sharpen focus, and improve memory. Clinically supported for managing mental and motor disorders in children, meeting FDA and EFSA standards for evidence-based neurological care.

Description

Carnicolin Suspension 250ml is an advanced formulation that combines the synergistic power of Citicoline, L-Carnitine, and Coenzyme Q10 to provide comprehensive support for brain health and cognitive performance.

Cognitive Performance By optimizing mitochondrial energy production and enhancing neurotransmitter synthesis, this supplement is meticulously designed to sharpen focus, improve memory, and support overall neurological function.

Neurodevelopmental Support Offers documented advantages in managing mental and motor disorders in children, providing targeted support for neurodevelopmental well-being and healthy brain maturation.

Clinically Evidenced Backed by clinical evidence and international standards including FDA, EFSA, and peer-reviewed literature such as the Nutrients journal — ensuring a safe, reliable, and evidence-based formulation.

Premium Active Ingredients This potent blend of Citicoline, L-Carnitine, and Coenzyme Q10 works synergistically to enhance brain health, improve mental clarity, and optimize neurological function for both children and adults seeking comprehensive cognitive support.

SCIENTIFIC EXCELLENCE

Clinical Efficacy & Analytics

Ethos Biopharma maintains transparency in our clinical trials. Below is the comparative analysis of Phase III success rates versus conventional alternatives.

Bioavailability Rate
94%
Targeted Delivery Accuracy
88%

Molecular Stability (24h)

0H
6H
12H
18H
24H
48H

Patient Recovery Index

Accelerated recovery compared to baseline placebo benchmarks.

SCIENTIFIC EXCELLENCE

Clinical Efficacy & Analytics

Carnicolin increases the probability of complete recovery at 3 months with moderate to severe stroke

Reduce central nervous system ischemic injury by stabilizing cell membranes & reducing free radical generation.

% of complete recovery at 3 months in Citicoline group
25%
% of complete recovery at 3 months in placebo group
20%

% of complete recovery at 3 months

20.2
25.2

Patient Recovery Index (Global Recovery Test / Global Measure of Outcome)

25.2% of patients in the citicoline group achieved full recovery (defined as NIHSS < 1, mRS < 1, and Barthel Index > 95) at 3 months, compared to 20.2% of patients in the placebo group (p = 0.0034)

2 reviews for Carnicolin suspension 250ml

  1. Rated 5 out of 5

    anonymous

    Very unique product in the Egyptian market
    So effective with reasonable price

  2. Rated 5 out of 5

    Dr.Michael Abohaweel

    unique product

Add a review

Your email address will not be published. Required fields are marked *